Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Differential Biomarkers of Response to Dimethyl Fumarate and Ocrelizumab in Multiple Sclerosis.

Saved in:
Bibliographic Details
Title: Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Differential Biomarkers of Response to Dimethyl Fumarate and Ocrelizumab in Multiple Sclerosis.
Authors: Mingione, Alessandra1,2 (AUTHOR), Corona, Andrea1,2 (AUTHOR), Monzani, Corinne1,2,3 (AUTHOR), Zollo, Alen1,2,4 (AUTHOR), Cirocco, Carola1,5 (AUTHOR), Zaccone, Tiziana3,6 (AUTHOR), Scavone, Mariangela4,7 (AUTHOR), Podda, Gian Marco4,5,8 (AUTHOR), Signorelli, Paola1,2,6 (AUTHOR), Miozzo, Monica2,7,8 (AUTHOR), Priori, Alberto2,3 (AUTHOR), Martinelli-Boneschi, Filippo1,2,3,4 (AUTHOR) filippo.martinelli@unimi.it
Source: International Journal of Molecular Sciences. Feb2026, Vol. 27 Issue 3, p1441. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16616596
DOI:10.3390/ijms27031441